DK468389A - 1-((diarylmethoxy)alkyl)pyrrolidiner og -piperidiner, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse - Google Patents
1-((diarylmethoxy)alkyl)pyrrolidiner og -piperidiner, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse Download PDFInfo
- Publication number
- DK468389A DK468389A DK468389A DK468389A DK468389A DK 468389 A DK468389 A DK 468389A DK 468389 A DK468389 A DK 468389A DK 468389 A DK468389 A DK 468389A DK 468389 A DK468389 A DK 468389A
- Authority
- DK
- Denmark
- Prior art keywords
- diarylmethoxy
- pyrrolidines
- piperidines
- procedures
- alkyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 150000003235 pyrrolidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03H—IMPEDANCE NETWORKS, e.g. RESONANT CIRCUITS; RESONATORS
- H03H7/00—Multiple-port networks comprising only passive electrical elements as network components
- H03H7/01—Frequency selective two-port networks
- H03H7/09—Filters comprising mutual inductance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8812430A FR2636946B1 (fr) | 1988-09-23 | 1988-09-23 | ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK468389D0 DK468389D0 (da) | 1989-09-22 |
| DK468389A true DK468389A (da) | 1990-03-24 |
Family
ID=9370298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK468389A DK468389A (da) | 1988-09-23 | 1989-09-22 | 1-((diarylmethoxy)alkyl)pyrrolidiner og -piperidiner, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4957927A (cs) |
| EP (1) | EP0360685B1 (cs) |
| JP (1) | JPH02121964A (cs) |
| AR (1) | AR246255A1 (cs) |
| AT (1) | ATE101132T1 (cs) |
| AU (1) | AU617530B2 (cs) |
| CA (1) | CA1327364C (cs) |
| CZ (1) | CZ279282B6 (cs) |
| DD (1) | DD284875A5 (cs) |
| DE (1) | DE68912860T2 (cs) |
| DK (1) | DK468389A (cs) |
| ES (1) | ES2062071T3 (cs) |
| FR (1) | FR2636946B1 (cs) |
| HU (1) | HU208422B (cs) |
| IE (1) | IE63648B1 (cs) |
| IL (1) | IL91689A0 (cs) |
| MA (1) | MA21631A1 (cs) |
| NO (1) | NO893764L (cs) |
| NZ (1) | NZ230744A (cs) |
| OA (1) | OA09135A (cs) |
| PT (1) | PT91783B (cs) |
| SU (1) | SU1757462A3 (cs) |
| TN (1) | TNSN89103A1 (cs) |
| YU (1) | YU170189A (cs) |
| ZA (1) | ZA897212B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE912759A1 (en) * | 1990-08-06 | 1992-02-12 | Smith Kline French Lab | Compounds |
| MX9100517A (es) * | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | Compuestos |
| ZA911813B (en) * | 1990-08-09 | 1991-12-24 | Sankyo Co | (benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma |
| GB9113031D0 (en) * | 1991-06-17 | 1991-08-07 | Smithkline Beecham Plc | Compounds |
| US5578639A (en) * | 1994-07-01 | 1996-11-26 | Warner-Lambert Company | PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| US6201124B1 (en) | 1995-12-21 | 2001-03-13 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| US5747523A (en) * | 1996-01-24 | 1998-05-05 | Guilford Pharmaceuticals Inc. | Substituted ethyl α,α-diarylmethyl ether derivatives |
| US6011035A (en) * | 1998-06-30 | 2000-01-04 | Neuromed Technologies Inc. | Calcium channel blockers |
| US6946475B1 (en) | 1999-04-07 | 2005-09-20 | University Of Virginia Patent Foundation | Anticancer calcium channel blockers |
| DE60011755T2 (de) * | 1999-04-07 | 2005-06-30 | The University Of Virginia Patent Foundation | Calciumkanalblocker als antikrebsmittel |
| US6930186B2 (en) * | 2001-06-13 | 2005-08-16 | Teva Pharmacetical Industries Ltd. | Process for the preparation of paroxetine substantially free of alkoxy impurities |
| CA2787673A1 (en) | 2010-03-01 | 2011-09-09 | Tau Therapeutics Llc | Cancer diagnosis and imaging |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1545094A (en) * | 1976-12-14 | 1979-05-02 | Gist Brocades Nv | Piperazine derivatives |
-
1988
- 1988-09-23 FR FR8812430A patent/FR2636946B1/fr not_active Expired - Lifetime
-
1989
- 1989-09-06 YU YU01701/89A patent/YU170189A/xx unknown
- 1989-09-19 IL IL91689A patent/IL91689A0/xx not_active IP Right Cessation
- 1989-09-19 DE DE68912860T patent/DE68912860T2/de not_active Expired - Fee Related
- 1989-09-19 EP EP89402561A patent/EP0360685B1/fr not_active Expired - Lifetime
- 1989-09-19 AT AT89402561T patent/ATE101132T1/de not_active IP Right Cessation
- 1989-09-19 ES ES89402561T patent/ES2062071T3/es not_active Expired - Lifetime
- 1989-09-20 MA MA21885A patent/MA21631A1/fr unknown
- 1989-09-20 JP JP1242360A patent/JPH02121964A/ja active Pending
- 1989-09-20 AR AR89314972A patent/AR246255A1/es active
- 1989-09-21 ZA ZA897212A patent/ZA897212B/xx unknown
- 1989-09-22 TN TNTNSN89103A patent/TNSN89103A1/fr unknown
- 1989-09-22 NZ NZ230744A patent/NZ230744A/en unknown
- 1989-09-22 CZ CS895409A patent/CZ279282B6/cs unknown
- 1989-09-22 NO NO89893764A patent/NO893764L/no unknown
- 1989-09-22 HU HU894981A patent/HU208422B/hu not_active IP Right Cessation
- 1989-09-22 DD DD89332899A patent/DD284875A5/de not_active IP Right Cessation
- 1989-09-22 AU AU41690/89A patent/AU617530B2/en not_active Ceased
- 1989-09-22 IE IE305089A patent/IE63648B1/en not_active IP Right Cessation
- 1989-09-22 US US07/410,705 patent/US4957927A/en not_active Expired - Fee Related
- 1989-09-22 OA OA59651A patent/OA09135A/xx unknown
- 1989-09-22 DK DK468389A patent/DK468389A/da not_active Application Discontinuation
- 1989-09-22 SU SU894742008A patent/SU1757462A3/ru active
- 1989-09-22 CA CA000612673A patent/CA1327364C/fr not_active Expired - Fee Related
- 1989-09-22 PT PT91783A patent/PT91783B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0360685B1 (fr) | 1994-02-02 |
| HUT52049A (en) | 1990-06-28 |
| SU1757462A3 (ru) | 1992-08-23 |
| CZ540989A3 (en) | 1994-11-16 |
| ZA897212B (en) | 1991-03-27 |
| IE63648B1 (en) | 1995-05-31 |
| DE68912860D1 (de) | 1994-03-17 |
| IL91689A0 (en) | 1990-06-10 |
| EP0360685A1 (fr) | 1990-03-28 |
| NZ230744A (en) | 1991-06-25 |
| DD284875A5 (de) | 1990-11-28 |
| ES2062071T3 (es) | 1994-12-16 |
| PT91783A (pt) | 1990-03-30 |
| IE893050L (en) | 1990-03-23 |
| US4957927A (en) | 1990-09-18 |
| JPH02121964A (ja) | 1990-05-09 |
| FR2636946B1 (fr) | 1990-11-02 |
| DK468389D0 (da) | 1989-09-22 |
| YU170189A (en) | 1991-02-28 |
| NO893764D0 (no) | 1989-09-22 |
| ATE101132T1 (de) | 1994-02-15 |
| FR2636946A1 (fr) | 1990-03-30 |
| CA1327364C (fr) | 1994-03-01 |
| TNSN89103A1 (fr) | 1991-02-04 |
| PT91783B (pt) | 1995-08-09 |
| OA09135A (fr) | 1991-10-31 |
| AR246255A1 (es) | 1994-07-29 |
| MA21631A1 (fr) | 1990-04-01 |
| NO893764L (no) | 1990-03-26 |
| AU4169089A (en) | 1990-03-29 |
| AU617530B2 (en) | 1991-11-28 |
| HU208422B (en) | 1993-10-28 |
| DE68912860T2 (de) | 1994-08-11 |
| CZ279282B6 (cs) | 1995-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK539789A (da) | Carbostyrilderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant carbostyrilderivat | |
| DK165112C (da) | 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse | |
| NO880443D0 (no) | N-heterosyklisk-n-(4-piperidyl)amider og farmasoeytiske preparater og fremgangsmaater for bruk av slike forbindelser. | |
| DK468389D0 (da) | 1-((diarylmethoxy)alkyl)pyrrolidiner og -piperidiner, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse | |
| DK556689D0 (da) | Antistof-konjugater, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende disse | |
| DK183986A (da) | Cyklopentylaetere, fremgangsmaade til fremstilling deraf og laegemiddelpraeparat indeholdende saadanne forbindelser | |
| DK244389A (da) | 2-aminoethanolderivat, fremgangsmaade til fremstilling deraf og praeparat indeholdende en saadan forbindelse | |
| DK396385D0 (da) | 2,3-dihydro-1h-indenderivater,fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser | |
| DK92789A (da) | Polypeptidderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse | |
| DK494088D0 (da) | 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse | |
| DK162841C (da) | N-(3-nitro-4-quinolyl)-4-karboxamidiner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende saadanne forbindelser | |
| DK607388D0 (da) | Polynukleotider, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DK262286A (da) | Fenantrenderivater, fremgangsmaade til fremstilling deraf og fungicide praeparater indeholdende saadanne forbindelser | |
| DK493988D0 (da) | 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser | |
| DK81287D0 (da) | 2-cyanobenzimidazolderivater, fremgangsmaade til fremstilling deraf og kombinations-fungicidpraeparater indeholdende saadanne forbindelser | |
| DK291188A (da) | 5-methoxyalkylammonium-tetrahydrofuran- og -tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater | |
| DK300989A (da) | Alaninderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DK155692A (da) | Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse | |
| DK21588A (da) | 4-arylcarbonyl-1-((4-morpholinyl)-alkyl)-1h-indoler, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser | |
| DK575387A (da) | Hydrofluorenderivater, fremgangsmaade til fremstilling deraf og praeparater indeholdende saadanne forbindelser | |
| DK161455C (da) | 1,2,4-triazolforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutiske fungicide praeprarater indeholdende disse | |
| DK26591A (da) | Cytidin-5'-diphosphatalkanoler og -glyceroler, fremgangsmaade til fremstilling heraf og praeparater indeholdende disse forbindelser | |
| DK623089A (da) | Trombolytiske proteiner, fremgangsmaade til fremstilling deraf og praeparater indeholdende disse forbindelser | |
| DK116990A (da) | Chromonderivat, fremgangsmaade til fremstilling deraf og praeparat indeholdende en saadan forbindelse | |
| DK162227C (da) | 3-aminopropoxyphenylderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater, som indeholder disse derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |